A23V2200/224

EDIBLE HYDRATION POD AND METHOD OF MANUFACTURING AN EDIBLE HYDRATION POD
20230363420 · 2023-11-16 ·

The disclosure provides edible hydration pods for hydrating animals and a method of manufacturing edible hydration pods. In one example, an enclosed, edible hydration pod for dogs is disclosed that includes: (1) a formed casing and (2) a frozen liquid that is enclosed by sealing the casing around the frozen liquid, wherein the casing is an edible and digestible casing that is flavored for dogs and is a transporting vessel for the liquid, wherein the casing includes a gelatin in the range of 35% to 55% and a polymer derived from cellulose.

COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION
20220279831 · 2022-09-08 · ·

A method for improving a nutritional status in a prenatal, pregnant or breastfeeding patient. The method includes providing a pharmaceutical composition in a single oral dosage form for administration to a prenatal, pregnant or breastfeeding patient. The pharmaceutical composition consists of vitamin D, iodine, vitamin B1, vitamin B6, vitamin B12, vitamin B2, vitamin B9, vitamin B3, vitamin E, vitamin A, vitamin C, iron, zinc, copper, magnesium, omega-3 fatty acids and one or more pharmaceutically acceptable carriers. The method further includes providing a daily dosage regimen for administering the single oral dosage form to the patient to improve a nutritional status in the patient.

COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION
20220279831 · 2022-09-08 · ·

A method for improving a nutritional status in a prenatal, pregnant or breastfeeding patient. The method includes providing a pharmaceutical composition in a single oral dosage form for administration to a prenatal, pregnant or breastfeeding patient. The pharmaceutical composition consists of vitamin D, iodine, vitamin B1, vitamin B6, vitamin B12, vitamin B2, vitamin B9, vitamin B3, vitamin E, vitamin A, vitamin C, iron, zinc, copper, magnesium, omega-3 fatty acids and one or more pharmaceutically acceptable carriers. The method further includes providing a daily dosage regimen for administering the single oral dosage form to the patient to improve a nutritional status in the patient.

GASTRO-RESISTANT MICROENCAPSULATES, AND USES THEREOF TO STIMULATE IN-VIVO ILEAL GLP-1 RELEASE IN A MAMMAL
20220280600 · 2022-09-08 · ·

A cold-gelated mono-nuclear microencapsulate comprises a unitary liquid core encapsulated within a gastro-resistant, ileal-sensitive, polymerized denatured protein membrane shell, wherein the liquid core comprises a GLP-1 release stimulating agent in a substantially solubilised form. The GLP-1 release stimulating agent is a native protein selected from native dairy protein, native vegetable protein or native egg protein.

GASTRO-RESISTANT MICROENCAPSULATES, AND USES THEREOF TO STIMULATE IN-VIVO ILEAL GLP-1 RELEASE IN A MAMMAL
20220280600 · 2022-09-08 · ·

A cold-gelated mono-nuclear microencapsulate comprises a unitary liquid core encapsulated within a gastro-resistant, ileal-sensitive, polymerized denatured protein membrane shell, wherein the liquid core comprises a GLP-1 release stimulating agent in a substantially solubilised form. The GLP-1 release stimulating agent is a native protein selected from native dairy protein, native vegetable protein or native egg protein.

SMOKING DEVICE COMPRISING AT LEAST ONE BREAKABLE FLAVOURING CAPSULE
20220287359 · 2022-09-15 ·

A smoking device including a tubular element containing tobacco and a filtering element connected to an end of the tubular element. The filtering element includes at least one breakable flavouring capsule which includes at least one core having at least one lipophilic substance and at least one flavouring agent dispersed or dissolved in the lipophilic substance; at least one breakable coating which coats the core and which has at least one chitosan having a weight average molecular weight (Mw) between 25 kDa and 400 kDa. Preferably, the breakable coating further includes at least one polyhydroxyalkanoate (PHA). The frangible coating that coats the core is able to preserve its hardness, and therefore its breakability, during use by the smoker, i.e. in the presence of humidity and heat that develop from the combustion of tobacco.

SMOKING DEVICE COMPRISING AT LEAST ONE BREAKABLE FLAVOURING CAPSULE
20220287359 · 2022-09-15 ·

A smoking device including a tubular element containing tobacco and a filtering element connected to an end of the tubular element. The filtering element includes at least one breakable flavouring capsule which includes at least one core having at least one lipophilic substance and at least one flavouring agent dispersed or dissolved in the lipophilic substance; at least one breakable coating which coats the core and which has at least one chitosan having a weight average molecular weight (Mw) between 25 kDa and 400 kDa. Preferably, the breakable coating further includes at least one polyhydroxyalkanoate (PHA). The frangible coating that coats the core is able to preserve its hardness, and therefore its breakability, during use by the smoker, i.e. in the presence of humidity and heat that develop from the combustion of tobacco.

DIETARY NUTRIENT COMPOSITIONS

Provided herein are dietary supplement compositions comprising a plurality of beadlets and an oil. Provided herein are also dietary supplement compositions comprising a plurality of mini-tabs and oil. The beadlets or mini-tabs comprise at least one nutrient that is miscible in aqueous solution, and the oil comprises at least one fat-soluble nutrient. The composition may be contained within one or more capsules, and be packaged with a scented insert.

DIETARY NUTRIENT COMPOSITIONS

Provided herein are dietary supplement compositions comprising a plurality of beadlets and an oil. Provided herein are also dietary supplement compositions comprising a plurality of mini-tabs and oil. The beadlets or mini-tabs comprise at least one nutrient that is miscible in aqueous solution, and the oil comprises at least one fat-soluble nutrient. The composition may be contained within one or more capsules, and be packaged with a scented insert.

Composition to improve athletic performance by supporting muscle protein synthesis and mental focus

The present invention generally relates to compositions and methods for supporting exercise performance or activities of daily living. The compositions described herein are pharmaceutical or nutritional compositions suitable for enhancing exercise performance. The compositions are based on a specially formulated mixture of essential amino acids (EAAs) with additional components. The compositions target support of muscle protein synthesis and reduction of muscle breakdown during exercise, increasing muscle blood flow during exercise, decreasing the perception of fatigue by supporting optimal availability of neurotransmitter precursors, providing energy for rapids bursts of exertion during exercise, and maintaining adequate electrolyte balance during exercise.